Meropenem dosing optimization on day 1 and steady state in c…

Emerging


1
Citations
37
Refs
2025
Year
Search Works
Work Details
MENU
0

Meropenem dosing optimization on day 1 and steady state in critically ill patients without significant renal impairment

Article 2025 EN Gold

This study aimed to characterize meropenem pharmacokinetics and optimise dosing for the initial and steady state in critically ill patients. Adult patients receiving meropenem were recruited, with sampling performed on days 1 (Occasion 1) and 3 (Occasion 2) of therapy. A composite target of free drug concentrations above the minimum inhibitory concentration for the entire dosing interval (100%ƒT >…

1

Citations

37

References

13

Authors

0.47

FWCI

Citations by Year
Last 1 years
Topics
Keywords
UN Sustainable Development Goals
1 SDGs
Authors & Affiliations
13 authors
#AuthorInstitutionsORCID
1 Helmi Sulaiman University of Malaya (MY)
2 Muhammad Azrai Rozali International Islamic Universi… (MY) —
3 Santosh Kumar Sreevatsav Adiraju The University of Queensland (AU)
4 Mohd Shahnaz Hasan University of Malaya (MY)
5 Janattul‐Ain Jamal Universiti Teknologi MARA Syst… (MY) Universiti Teknologi MARA (MY)
6 Xin Liu The University of Queensland (AU)
7 Mohd Basri Mat Nor International Islamic Universi… (MY)
8 Mohd Zulfakar Mazlan Universiti Sains Malaysia (MY) Hospital Universiti Sains Mala… (MY)
9 Mohamad Irfan Othman Jailani University of Malaya (MY) —
10 Zeti Norfidiyati Salmuna Universiti Sains Malaysia (MY) Hospital Universiti Sains Mala… (MY) —
11 Steven C. Wallis The University of Queensland (AU)
12 Jason Alexander Roberts The University of Queensland (AU) Université de Montpellier (FR) +3
13 Mohd Hafiz Abdul-Aziz Corresponding The University of Queensland (AU)

Data: OpenAlex